(Total Views: 687)
Posted On: 11/24/2020 5:49:11 PM
Post# of 145872
"The results indicate that patients who received SACCOVIDTM had a 60% better chance to achieve clinical recovery than those who received placebo (P=0.005). The median time to recovery was 6 days for patients treated with SACCOVIDTM compared with 10 days in the placebo group. In addition, the risk of death or respiratory failure is reduced by more than 50%,” said Dr. Pan Zheng, MD, PhD, Chief Medical Officer and co-founder of OncoImmune."
Seems to me that since no p-value given for mortality unlike for clinical recovery, effect on mortality wasn't stat sig. Oldest trick in biotech...
Anyway, seems they will need another pivotal trial unlike us.
Seems to me that since no p-value given for mortality unlike for clinical recovery, effect on mortality wasn't stat sig. Oldest trick in biotech...
Anyway, seems they will need another pivotal trial unlike us.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)